ApiFix

Company Overview

Snapshot

Founded in March 2011 by Yizhar Floman and Uri Arnin, ApiFix operates with 11–50 employees. The company raised a total of $8 million across three funding rounds. In April 2020, ApiFix was acquired by Orthopediatrics.

Business overview

ApiFix is a Health Tech & Life Sciences company specializing in Medical Devices and Medical Treatment & Therapeutics. The company develops a minimally invasive scoliosis correction system for treating adolescent idiopathic scoliosis. Its core technology, the ApiFix Internal Brace System, uses a minimal surgical intervention followed by a multi-month correction process aided by physical therapy. ApiFix serves the healthcare industry, targeting providers and patients with its innovative medical products.

Strategic signal

In April 2020, ApiFix was acquired by Orthopediatrics for at least $67 million, according to news reports. This acquisition highlights the strategic value of ApiFix's minimally invasive scoliosis treatment technology within the pediatric orthopedic market and signals a successful exit for the company's investors and a significant expansion for Orthopediatrics' product portfolio.

Company Intelligence Q&A

When was ApiFix acquired and by whom?

ApiFix was acquired by Orthopediatrics in April 2020.

What was a significant regulatory achievement for ApiFix?

In August 2019, ApiFix received FDA approval to commercialize its MID-C System for the motion-preserving deformity treatment of progressive idiopathic scoliosis in adolescents.

Which investors participated in ApiFix's April 2019 funding round?

In April 2019, ApiFix received funding from The Trendlines Group and B. Braun Melsungen AG.

When did ApiFix announce new leadership?

ApiFix Ltd. announced new leadership in January 2018.

When did ApiFix complete its first cases in North America?

In September 2017, ApiFix completed its first cases in North America at IWK Health Centre Hospital in Halifax, Canada.